Form 8-K - Current report:
SEC Accession No. 0001493152-24-021615
Filing Date
2024-05-28
Accepted
2024-05-28 16:15:29
Documents
16
Period of Report
2024-05-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48484
2 ex10-1.htm EX-10.1 309586
3 ex10-2.htm EX-10.2 46422
4 ex10-3.htm EX-10.3 118331
  Complete submission text file 0001493152-24-021615.txt   793003

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE nrxs-20240521.xsd EX-101.SCH 3015
6 XBRL LABEL FILE nrxs-20240521_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE nrxs-20240521_pre.xml EX-101.PRE 22359
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3790
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 24992023
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)